Respiratory virus vaccine recommendations

Find the latest medical society recommendations on respiratory virus vaccines. 

Influenza (seasonal flu) vaccine recommendations

Annual flu vaccination is recommended for everyone ages 6 months and older without medical contraindications.

See recommendations from:

• American Academy of Family Physicians (AAFP)
• American Academy of Pediatrics (AAP)
• American College of Obstetricians and Gynecologists (ACOG)
• American College of Cardiology (ACC)
• American College of Physicians (ACP)
• Infectious Disease Society of American (IDSA)
• Centers for Disease Control and Prevention (CDC)

Respiratory syncytial virus (RSV) vaccine recommendations

A one-time RSV vaccine is recommended for adults age 75 and older, and for ages 50–74 at increased risk. 

See recommendations from:

• Centers for Disease Control and Prevention (CDC)
• American Academy of Family Physicians (AAFP)
• American College of Cardiology (ACC)

During September–January, the RSV vaccine (Pfizer's Abrysvo) is recommended for pregnant patients during weeks 32-36 of pregnancy.

See recommendations from:

• Centers for Disease Control and Prevention (CDC)
• American Academy of Family Physicians (AAFP)
• American College of Obstetricians and Gynecologists (ACOG)

Infants under 8 months whose parent did not receive the RSV vaccine during pregnancy are recommended to receive nirsevimab or clesrovimab.

See recommendations from:

• Centers for Disease Control and Prevention (CDC)
• American Academy of Family Physicians (AAFP)
• American Academy of Pediatrics (AAP)

Infants and children 8 through 19 months of age at high risk of severe RSV disease and entering their second RSV season are recommended to receive nirsevimab, regardless of the RSV vaccination status of the pregnant parent or the child’s prior receipt of nirsevimab or clesrovimab. 

See recommendations from:

• Centers for Disease Control and Prevention (CDC)
• American Academy of Family Physicians (AAFP)
• American Academy of Pediatrics (AAP)

All adults and adolescents who are immunocompromised are recommended to receive an age-appropriate RSV vaccine, and for immunocompromised patients <18 years, administration should be guided by shared decision-making. 

See recommendations from:

• Infectious Disease Society of American (IDSA)

COVID-19 vaccine recommendations

All children ages 6 months through 18 years of age are eligible to receive a single dose of age-appropriate updated COVID-19 vaccine; all children 6-23 months are recommended to be vaccinated and a risk-based single dose approach is recommended for children and teens 2-18 years.

See recommendations from:

• American Academy of Family Physicians (AAFP)
• American Academy of Pediatrics (AAP)

All children 6 months through 18 years of age who are moderately or severely immunocompromised are recommended to receive at least 1 (IDSA) or 2 (AAP) additional doses of age-appropriate updated COVID-19 vaccine depending on previous vaccination status.

See recommendations from:

• American Academy of Family Physicians (AAFP)
• Infectious Disease Society of American (IDSA)
• American Academy of Pediatrics (AAP)

All pregnant and lactating individuals are recommended to receive an updated COVID-19 vaccine.

See recommendations from:

• American Academy of Family Physicians (AAFP)
• American College of Obstetricians and Gynecologists (ACOG)

All adults 18 years and older without contraindications, including those living in post-acute and long-term care facilities or who are immunocompromised, are recommended to receive at least one dose of the updated COVID-19 vaccine.

See recommendations from:

• American Academy of Family Physicians (AAFP)
• Post-Acute and Long-Term Care Medical Association (PALTmed)
• Infectious Disease Society of America (IDSA)
• American College of Cardiology (ACC)